花园生物：子公司产品中选第十一批全国药品集中采购

Core Viewpoint - Garden Biologics (300401.SZ) announced that its subsidiary, Zhejiang Garden Pharmaceutical Co., Ltd., has been selected in the 11th batch of national centralized drug procurement, which will enhance the market penetration of its Alendronate Sodium Tablets and promote the development of its pharmaceutical formulation business [1] Group 1 - The selection of Alendronate Sodium Tablets in the national procurement will facilitate rapid market expansion for the product [1] - This development is expected to increase the market share of the product, thereby enriching the company's product pipeline [1] - The outcome will also enhance the brand influence of the company in the pharmaceutical industry [1]